Achillion Pharmaceuticals, Inc.New Haven, CT, United States (NASDAQ (GM): ACHN)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

Achillion Income Statement

All amounts in millions of except per share amounts.
View: Annual
Dec 07 Dec 06 Dec 05
Revenue 4.0 3.3 8.5
Cost of Goods Sold -- -- --
Gross Profit -- -- --
Gross Profit Margin 0.0% 0.0% 0.0%
SG&A Expense 35.6 27.0 20.1
Depreciation & Amortization (1.0) 0.6 1.1
Operating Income (30.6) (24.3) (12.7)
Operating Margin -- -- --
Nonoperating Income 2.5 1.1 0.2
Nonoperating Expenses 1.0 1.0 1.2
Income Before Taxes (29.1) (24.1) (13.7)
Income Taxes (1.0) (0.1) (0.1)
Net Income After Taxes (28.1) (24.1) (13.6)

Continuing Operations (28.1) (24.1) (13.6)
Discontinued Operations -- -- --
Total Operations (28.1) (24.1) (13.6)
Total Net Income (28.1) (24.1) (13.6)
Net Profit Margin -- -- --

Diluted EPS from Total Net Income ($) (1.80) (9.35) (4.12)
Dividends per Share -- -- --
Edgar Online logo
This data is provided as per license from EDGAR Online